Esther Barreiro
Carlos III Health Institute
284 Papers
1.2K Citations
Esther Barreiro is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Medicine & COPD. The author has an hindex of 54, co-authored 263 publications. Previous affiliations of Esther Barreiro include Autonomous University of Barcelona & European University of Madrid.
Chat about Author
Papers
Recomendaciones SEPAR de diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas
Felipe Villar Álvarez,Ignacio Muguruza Trueba,José Belda Sanchis,Laureano Molins López-Rodó,Pedro Rodríguez Suárez,Julio Sánchez de Cos Escuín,Esther Barreiro,M. Henar Borrego Pintado,Carlos Disdier Vicente,Javier Flandes Aldeyturriaga,Pablo Gámez García,Pilar Garrido Lopez,Pablo León Atance,José Miguel Izquierdo Elena,Nuria María Novoa Valentín,Juan José Rivas de Andrés,Íñigo Royo Crespo,Ángel Salvatierra Velázquez,Luis Seijo Maceiras,Segismundo Solano Reina,David Aguiar Bujanda,Régulo José Ávila Martínez,José Ignacio de Granda Orive,Eva de Higes Martinez,Vicente Diaz-Hellín Gude,Raúl Embún Flor,Jorge Freixinet Gilart,María Dolores García Jiménez,Fátima Hermoso Alarza,Samuel Hernandez Sarmiento,Antonio Francisco Honguero Martínez,Carlos A. Jiménez Ruiz,Iker López Sanz,Andrea Mariscal de Alba,Primitivo Martínez Vallina,Patricia Menal Muñoz,Laura Mezquita Pérez,Maria Eugenia Olmedo Garcia,Carlos A. Rombolá,Iñigo San Miguel Arregui,María del Valle Somiedo Gutiérrez,Ana Triviño Ramírez,Joan Carles Trujillo Reyes,Carmen Vallejo,Paz Vaquero Lozano,Gonzalo Varela Simó,Javier J. Zulueta +46 more
TL;DR: A handbook on recommendations for the diagnosis and treatment of non-small cell lung cancer, with recommendations on the follow-up of lung cancer patients and surgical and endoscopic palliative interventions in advanced stages is published.
Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer
Jordi Alcaraz,Josep L. Carrasco,Laura Millares,Iuliana-Cristiana Luis,Francisco J. Fernández-Porras,Anabel Martinez-Romero,Natalia Díaz-Valdivia,Julio Sánchez de Cos,Ramon Rami-Porta,Luis Seijo,Josep Ramírez,Maria J. Pajares,Noemi Reguart,Esther Barreiro,Eduard Monsó +14 more
TL;DR: Patients with large histologic coverage of fibrillar collagens and α-SMA + TAFs are identified to be at higher risk of recurrence and death, supporting that they could be considered for adjuvant therapy.
43
Protein carbonylation and muscle function in COPD and other conditions.
TL;DR: The review summarizes the effects of protein carbonylation on muscles in several models and conditions such as COPD, disuse muscle atrophy, cancer cachexia, sepsis, and aging.
42
N-acetylcysteine increases manganese superoxide dismutase activity in septic rat diaphragms.
TL;DR: Data produced from this study indicate that high doses of N-acetylcysteine induces manganese superoxide dismutase, as well as preserves its activity, possibly by preventing nitration of critical tyrosine residues of the enzyme.
42
Effects of the beta2 agonist formoterol on atrophy signaling, autophagy, and muscle phenotype in respiratory and limb muscles of rats with cancer-induced cachexia.
Anna Salazar-Degracia,Sílvia Busquets,Josep M. Argilés,Núria Bargalló-Gispert,Francisco J. López-Soriano,Esther Barreiro,Esther Barreiro +6 more
TL;DR: The results reported in this study have relevant therapeutic implications as they showed beneficial effects of the beta2 agonist formoterol in the cachectic muscles through several key biological pathways.
42